Navigation Links
Novavax CEO to Present at the World Vaccine Congress 2009, Lyon, France
Date:10/6/2009

ROCKVILLE, Md., Oct. 6 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and CEO of Novavax, will be making two presentations at the World Vaccine Congress 2009 conference on October 7th, 2009 at the Palais des Congres de Lyon, Lyon, France. The first presentation by Dr. Singhvi titled, 'Innovative Approaches to RSV vaccine development and VLP based vaccines' will be presented under the 'FUTURE DIRECTION OF VACCINE R&D' section. The second presentation, 'How to advance manufacturing using scalable solutions' will be presented under the 'CELL CULTURE BASED PRODUCTION -- THE NEXT FRONTIER?' session.

ABOUT NOVAVAX

Novavax, Inc. (Nasdaq: NVAX) a clinical-stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent, recombinant vaccines utilizing new and efficient manufacturing approaches. Additional information about Novavax is available at www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.

SOURCE Novavax, Inc.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Novavax Announces Board of Director Changes
2. NOVAVAX Announces Positive Results for the Second Phase II Clinical Trial of its Trivalent Seasonal Influenza Virus-like Particle (VLP) Vaccine Candidate
3. NOVAVAX Virus-Like Particle Vaccine Protects Against 2009 Pandemic H1N1 Influenza Virus
4. Novavax Reports Second Quarter 2009 Financial Results
5. Novavax Announces Appointment of Frederick W. Driscoll as Vice President, Chief Financial Officer and Treasurer
6. Novavax Announces Release Date of 2009 Second Quarter, Financial Results and Investor Conference Call
7. Novavax Announces Selection of a Respiratory Syncytial Virus Vaccine Candidate for Advanced Preclinical Studies
8. Novavax Announces Appointment of John J. Trizzino as Senior Vice President, International and Government Alliances
9. Novavax Announces Repayment of $5 Million of Convertible Debt
10. Cadila Pharmaceuticals Launches Joint Venture With Novavax in India
11. Spanish Government Selects Novavaxs VLP Technology for Comprehensive Flu Vaccine Solution in Spain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... Sequenom, Inc. (Nasdaq: SQNM ), ... and Mr. David Pendarvis to its board of ... ,, Kenneth F. Buechler, Ph.D., was president, chief ... 1988 to 1994, Dr. Buechler was Biosite,s director ... was a senior research scientist for the diagnostics ...
(Date:12/16/2009)... the ultimate CHO cell culture supplement? InVitria has what scientists ... culture media supplement that improves the growth and productivity of ... performance, Zap-CHO is an animal free, well defined and consistent ... ... Collins, CO (PRWEB) December 16, 2009 -- Scientists working with ...
(Date:12/16/2009)... introduces HSP-A Soy Peptone. HSP A has been found to ... ... (PRWEB) December 16, 2009 -- Nu-Tek BioSciences, LLC. ( www.nu-tekproducts.com ... Soy Peptone. HSP-A, previously manufactured by Nutricepts, Inc. (Burnsville, Mn), ... improve growth rates and yields. HSP-A has been found to ...
(Date:12/15/2009)... -- Epeius Biotechnologies Corporation, an emerging leader in ... validation of the cutting-edge science behind its lead ... the world rediscovered the Cyclin G1 gene ... pathogenesis and disease progression, and thus a prime ... NIH National Cancer Institute investigating the role of ...
Breaking Biology Technology:Sequenom Appoints Two New Board Members 2Sequenom Appoints Two New Board Members 3Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3
... of improving business processes with enterprise-centric Internet tools is hardly ... of adoption means that reluctant business leaders need an education ... hardly be attributed to a lack of information. Building on ... Web 2.0? " bloggers like Dion Hinchcliffe , ...
... growing belief that whenever a state company is acquired by ... the state's economy. But the recent acquisition of Madison's ... . has a real chance to benefit both parties and ... ,The win-win view not only was offered by executives in ...
... - Five University of Wisconsin-Madison faculty have ... the National Academies . , ,Election to the National ... , the National Academy of Engineering , the ... - is considered one of the highest honors accorded ...
Other Biology Technology:Businesses are slow to adopt Web 2.0 concepts 2Businesses are slow to adopt Web 2.0 concepts 3Businesses are slow to adopt Web 2.0 concepts 4Anatomy of a deal: CDW and Berbee 2Anatomy of a deal: CDW and Berbee 3Anatomy of a deal: CDW and Berbee 4
(Date:12/16/2009)... December 15, 2009 Signal Hill, CA Tom ... public and president of Bowman Global Change, has developed ... the fourth Intergovernmental Panel on Climate Change (IPCC) report ... to the authentic scientific information they need to make ... Bowman created the new format as a means to ...
(Date:12/16/2009)... NEW YORK, Dec. 1 iQor, a global ... in the 2009 InfoWorld 100 Awards Top ... system, TeQ21. This was the first submission for iQor. ... prestigious list of companies," said Vikas Kapoor, president and ... we do business, allowing us to work faster, smarter ...
(Date:12/16/2009)... Dec. 2 DigitalPersona, Inc., a ... today announced an agreement with IBM to ... biometric fingerprint technology on IBM SurePOS 500 ... allows point-of-sale applications to more easily and ... can be linked to the individuals who ...
Breaking Biology News(10 mins):Bowman creates graphic translation of climate change data 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 1Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 2Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 3Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 4Schwarzenegger Administration Sued for Allowing Health Insurance Companies to Deny Autism Care 50557 5Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 1Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 2Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 3Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 4Video 3A Axel Ullrich Named Winner of 2009 Dr Paul Janssen Award for Biomedical Research 12873 5Test Before Corneal Transplant May Improve Outcome 50548 1Test Before Corneal Transplant May Improve Outcome 50548 2
... developed the first small molecule that can reversibly activate ... the way for drugs that can treat low blood ... sodium channel (ENaC) controls sodium flow across many tissues ... is vital to maintaining proper salt balance and blood ...
... Lanka are three times more likely to suffer from ... ethnic Norwegians. This finding comes from the Norwegian Institute ... registered in the Medical Birth Registry of Norway over ... that 90 percent of pregnant women experience some degree ...
... Cancer Conference, jointly organized by the European Society for ... Study of Lung Cancer (IASLC) in Geneva, Switzerland highlight ... development of lung cancer. , Experts agree that ... contributes to lung cancer development. But other factors can ...
Other Biology News:Extreme nausea and vomiting varies among pregnant women from different countries 2Viruses may play a role in lung cancer development 2